Feb 03, 2017 11:30 am UTC| Business
- Pipeline strengthens with addition of AM-125 as third clinical-stage program- Acquisition of assets related to innovative betahistine product for intranasal delivery - Betahistine is one of the most widely used...
T2 Biosystems Announces 2016 Fourth Quarter and Full-Year Results Release and Conference Call Date
Feb 03, 2017 11:30 am UTC| Business
LEXINGTON, Mass., Feb. 03, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 fourth quarter and full-year financial results after the market closes on Monday, February 13, 2017. In...
Feb 03, 2017 11:18 am UTC| Business
Dublin, Feb. 03, 2017 -- Research and Markets has announced the addition of the "Global Cell Therapy Market Clinical Pipeline Outlook 2022" report to their offering. The Global...
Global HIV Vaccine Market & Clinical Trial Outlook 2022
Feb 03, 2017 11:14 am UTC| Business
Dublin, Feb. 03, 2017 -- Research and Markets has announced the addition of the "Global HIV Vaccine Market Clinical Trial Outlook 2022" report to their offering. The Global HIV...
Feb 03, 2017 11:06 am UTC| Business
Dublin, Feb. 03, 2017 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies" to their...
Global Animal Biotechnology Technologies, Markets and Companies 2017-2026
Feb 03, 2017 11:00 am UTC| Business
Dublin, Feb. 03, 2017 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering. ...
Sunshine Heart Appoints Steve Brandt and Matthew E. Likens to Board of Directors
Feb 03, 2017 11:00 am UTC| Business
EDEN PRAIRIE, Minn., Feb. 03, 2017 -- Sunshine Heart,Inc. (NASDAQ:SSH) (ASX:SHC) today announced that Steven F. Brandt and Matthew E. Likens have been appointed to the Company’s Board of Directors. Mr. Brandt is a...